Position in ADCT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$201,337
+$25,960 QoQ
Shares Held
53,690
+8.1% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $88,544,808 across 37 Drug Manufacturers - Specialty & Generic names. ADCT ranks #29 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
304,172 | $15,722,650 | |
| 2 | ZTS |
Zoetis Inc.
|
114,814 | $13,572,162 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21,171 | $12,553,979 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
53,053 | $6,989,202 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
244,343 | $5,847,127 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
67,088 | $5,088,624 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
211,317 | $4,386,940 | |
| 8 | VTRS |
Viatris Inc
|
269,168 | $3,636,459 |
All Filings in ADCT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $201,337 | 53,690 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $175,377 | 49,682 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $120,196 | 30,049 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $120,672 | 45,027 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $64,136 | 45,487 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $61,922 | 31,117 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $135,730 | 43,089 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $59,439 | 18,810 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||